» Articles » PMID: 22252759

Imbalance Between Th17 and Regulatory T-cells in Systemic Lupus Erythematosus

Overview
Specialty Cell Biology
Date 2012 Jan 19
PMID 22252759
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Impaired function of regulatory T-cells (Treg) leads to a failure in immune tolerance and triggers autoimmunity. We analyzed whether the deficiency in Treg in systemic lupus erythematosus (SLE) is accompanied by an increase in effector T-cell responses. We studied the frequencies of IL-17A (Th17) and IFNg (Th1) producing CD4(+) T-cells by flow cytometric detection of intracellular cytokines in PMA/ionomycin stimulated blood lymphocytes from seven patients with active SLE, eight with SLE in remission, and 11 healthy controls. Circulating Treg were evaluated as CD4(+)CD25(+) lymphocytes expressing FoxP3. There was no difference in the percentage of Treg cells between the groups, but their absolute counts were decreased in active SLE (5 [1-7] cells/μL) compared to inactive SLE (11 [6-15]; p = 0.05) and healthy controls (16 [10-20]; p 〈 0.01). Both the frequency and numbers of Th1 cells were decreased in SLE compared to controls. No difference was observed in the number of Th17 cells, which resulted in a decreased Th1/Th17 ratio. In parallel, a higher Treg/Th17 ratio in healthy controls (2.2 [1.8-3.6]) compared to active SLE (1.1 [1.0-2.1]; p 〈 0.05) was observed. There was a correlation between the number of Treg cells and disease activity status (SLEDAI, r = -0.59). SLE patients in the active phase of the disease are characterized by a deficiency in Treg cells and decreased Treg/Th17 ratio. This suggests that the imbalance between major T-cells subsets might be responsible for an increased proinflammatory response in the exacerbation of SLE.

Citing Articles

Dose effect of corticosteroids on peripheral lymphocyte profiles in patients with systemic lupus erythematosus.

Chen D, Sun F, Miao M, Wang Y, Jin Y, Zhang X Clin Rheumatol. 2025; 44(2):669-679.

PMID: 39760906 DOI: 10.1007/s10067-024-07254-2.


CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives.

Zhou J, Lei B, Shi F, Luo X, Wu K, Xu Y Front Immunol. 2025; 15:1476859.

PMID: 39749335 PMC: 11694027. DOI: 10.3389/fimmu.2024.1476859.


Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis.

Huang J, Li X, Zhu Q, Wang M, Xie Z, Zhao T Front Immunol. 2024; 15():1425847.

PMID: 39086480 PMC: 11288813. DOI: 10.3389/fimmu.2024.1425847.


Regulatory T Cell Dysfunction in Autoimmune Diseases.

Honing D, Luiten R, Matos T Int J Mol Sci. 2024; 25(13).

PMID: 39000278 PMC: 11241405. DOI: 10.3390/ijms25137171.


Elevated levels of IL-12/IL-23p40 in Nova Scotia Duck Tolling Retrievers with autoimmune disease and lymphoma.

Nilsson M, Kozyrev S, Saellstrom S, Johansson S, Andersson G, Lindblad-Toh K Sci Rep. 2024; 14(1):11624.

PMID: 38773194 PMC: 11109178. DOI: 10.1038/s41598-024-62265-y.